Replies to post #325311 on Bioelectronics Corp (BIEL)

[The_Pro]

Answer to questions:

1. See the end of year letter from COB Richard Staelin dated 12/22/23.

Here's what specifically he stated:

"Finally, we completed a new design for our RecoveryRx product that is better suited for surgery incisions and is 50% more powerful than the current version. We have already manufactured a limited supply of these units and are planning to apply for an expedited 510(k) from the FDA in the near future."

2. Also op cit letter dated 12/22/23 by COB Richard Staelin:

News on the sales front is more mixed. We brought in two new distributors for Bulgaria and the Netherlands and will relaunch in Australia in early 2024.

You can read his letter here:

https://finance.yahoo.com/news/end-message-chairman-board-bioelectronics-205500227.html


I did some research but can't find any performance specs, clinical-evidence trials going on etc about the new and improved RecoveryRx. The 50% enhanced version.

[gimmee greenbacks]

https://www.globenewswire.com/news-release/2023/12/22/2800819/0/en/End-of-Year-Message-From-the-Chairman-of-the-Board-of-BioElectronics.html




BIEL